Wie wenn es das alles schon gäbe, wie wenn Stammzellen bereits Leben retten könnten. more

While exciting discoveries pour out of the world's academic stem cell laboratories, promising a new age of regenerative medicine to repair failing organs, companies trying to commercialise stem cells have endured a torrid couple of years. more

Schweizer Investoren finanzieren langfristiges Programm zur Entwicklung von Arzneistoffen auf der Basis von Nanopartikeln more

Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions and particularly oncology, today announced that the New Drug Application (NDA) for the 6 month formulation of Trelstar® (triptorelin pamoate) has been accepted for filing by the United States (U.S.) Food and Drug Administration (FDA). more

EuropaBio and EBE would like to congratulate the European Commission on its draft Communication and proposed Council Recommendation on Rare Diseases. - Swiss Biotech Association is member of Europa Bio more

L'extension de Merck Serono à Corsier- sur-Vevey (VD) est sur les rails. Toutes les oppositions ayant été levées, le groupe de biotechnologie a posé hier la première pierre des travaux d'agrandissement de son site devises à 500 millions de francs. more

Erweiterung des Standorts in Corsier-sur-Vevey, Schweiz, wird die Herstellung innovativer Biopharmazeutika für die Behandlung von Krankheiten mit hohem ungedecktem medizinischem Bedarf ermöglichen - 300-Millionen-Euro-Investition schafft mehr als 200 qualifizierte Arbeitsplätze more

Deux millions et demi de personnes ont été infectées l'an dernier dans le monde par le virus du sida. Presque autant en sont mortes. Pas les mêmes: entre la contamination et le décès, il y a les années d'ignorance meurtrière, d'incompréhension, de souffrance, d'exclusion, de solitude. more

EuropaBio, the European Biotech Industry Association, acknowledges the review of Directive 86/609, the laboratory animal protection Directive, but calls for a reduction of the bureaucratic burden the Directive places on SMEs. more

Syngenta announced today that it has signed and closed an agreement to acquire SPS Argentina SA (SPS), a company primarily specialized in the development, production and marketing of soybean, corn and sunflower. more

Jugendliche haben viele Fragen zu Naturwissenschaften und Technik. SGCI Chemie Pharma Schweiz, der Branchenverband der chemisch-pharmazeutischen Industrie, lässt sie mit diesen nicht allein: more

Santhera Pharmaceuticals (SIX: SANN), a Swiss specialty pharmaceutical company focused on neuromuscular diseases, announced today that it has raised gross proceeds of CHF 15.9 million in a private placement with Ares Life Sciences, an investment vehicle established by the Bertarelli family. Santhera sold 370,082 new registered common shares at a price of CHF 43.00 per share representing a premium of 3.7% over the volume-weighted average share price of the last five trading days. more